Clinuvel Pharmaceuticals

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Company

Indicator

Code Company Date Close Change Indicator Value Signal

Trading Performance

1st timeframe trend

Score

-0.35

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 26 17.5 0.54% 1.17% 9.2% -6.1% 55.8%
SHORT 27 11.9 0.33% 0.50% 5.3% -7.9% -93.7%

Summary

Technical Analysis


The Tricklar short term trend indicator (T1) highlights the high points and low points associated with the individual bars. As such, successive rallies penetrating preceding high points whilst cancelling preceding lower troughs offer a BULLISH indication in the second time frame. Conversely, failure of rallies to penetrate previous Lower peaks whilst maintaining prices below the previous lower troughs indicates BEARISH trends in the second timeframe.

Calculation: Tricklar short trend (T1):
1) [BULLISH] An uptrend is a succession of higher highs and higher lows;
2) [BEARISH] A downtrend is a succession of lower highs and lower lows;


PROFILE: Clinuvel Pharmaceuticals (CUV.AX)


Stock Exchange: ASX
Company: Clinuvel Pharmaceuticals
Ticker Codes: | CUV.AX | ASX:CUV |

About Clinuvel Pharmaceuticals (ASX:CUV):

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing drugs for the treatment of a range of severe skin disorders. Its lead drug compound is SCENESSE, a medicinal photoprotective and repigmentation drug that has completed Phase II and III trials in the United States and Europe, which is used for the prevention of phototoxicity in adults with erythropoietic protoporphyria. The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue that acts as a potent skin protectant; and VLRX001, an addition to the family of melanocortin analogues, which provoke increased and prolonged cellular activity. It has operations in Europe, the United States, and Singapore. The company is headquartered in Melbourne, Australia.

Top 10:

1st timeframe trend

Download
Company Close Change(%) Volume Value Signal
VOC Vocus Communications 2.92 1.4 2,603,772 -1 BEARISH
IMF IMF 3.2 1.3 111,991 -1 BEARISH
AJM Altura Mining 0.1 1 7,442,738 -1 BEARISH
PAI Platinum Asia Investments 0.98 0 800,298 -1 BEARISH
TGR Tassal 4.72 0 693,373 -1 BEARISH
ZEL Zeolite Australia 6.31 -0.2 5,906 -1 BEARISH
ASX Australian Stock Exchange 84.55 -0.3 391,304 -1 BEARISH
XMJ ASX 200 Materials 13000.5 -0.4 0 -1 BEARISH
MCY Mighty River Power 4.67 -0.4 9,235 -1 BEARISH
IDX Integral Diagnostics 3.21 -1.2 45,901 -1 BEARISH